These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 2902605)

  • 21. Huntington's disease: a clinical, genetic and molecular model for polyglutamine repeat disorders.
    Harper PS
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):957-61. PubMed ID: 10434293
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical and genetic aspects of Huntington's disease. Study of 28 patients].
    Alonso ME; Nieto D
    Rev Invest Clin; 1985; 37(2):125-30. PubMed ID: 2930890
    [No Abstract]   [Full Text] [Related]  

  • 23. Neurodegenerative disease: Tau is linked to cognitive decline in Huntington disease.
    Wood H
    Nat Rev Neurol; 2015 Jun; 11(6):310. PubMed ID: 26008995
    [No Abstract]   [Full Text] [Related]  

  • 24. Molecular genetics of human chromosome 4.
    Gusella JA; Gilliam TC; MacDonald ME; Cheng SV; Tanzi RE
    J Med Genet; 1986 Jun; 23(3):193-9. PubMed ID: 2941587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Triplet repeat mutation length gains correlate with cell-type specific vulnerability in Huntington disease brain.
    Shelbourne PF; Keller-McGandy C; Bi WL; Yoon SR; Dubeau L; Veitch NJ; Vonsattel JP; Wexler NS; ; Arnheim N; Augood SJ
    Hum Mol Genet; 2007 May; 16(10):1133-42. PubMed ID: 17409200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Molecular-genetic analysis of Huntington chorea (review of the foreign literature)].
    Ivanova-Smolenskaia IA; Mzhel'skaia TI; Milovidov IuK; Gulevskaia TS; Markova ED
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1992; 92(4):97-100. PubMed ID: 1360738
    [No Abstract]   [Full Text] [Related]  

  • 27. When Huntington's disease comes early.
    Dolgin E
    Nature; 2018 May; 557(7707):S44-S45. PubMed ID: 29844553
    [No Abstract]   [Full Text] [Related]  

  • 28. The neuropathological features of neuroacanthocytosis.
    Rinne JO; Daniel SE; Scaravilli F; Pires M; Harding AE; Marsden CD
    Mov Disord; 1994 May; 9(3):297-304. PubMed ID: 8041370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Autopsy of 2 siblings with Huntington's disease].
    Chen CL
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1987 Dec; 20(6):369-71. PubMed ID: 2966053
    [No Abstract]   [Full Text] [Related]  

  • 30. DNA diagnosis of autosomal dominant and recessive diseases.
    Cassiman JJ
    Birth Defects Orig Artic Ser; 1987; 23(2):97-114. PubMed ID: 2885043
    [No Abstract]   [Full Text] [Related]  

  • 31. History of genetic disease: the molecular genetics of Huntington disease - a history.
    Bates GP
    Nat Rev Genet; 2005 Oct; 6(10):766-73. PubMed ID: 16136077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An anonymous genomic clone that detects a frequent RFLP adjacent to the D4S10 (G8) marker and Huntington's disease.
    Carlock LR; Vo TD; DeHaven CR; Murray JC
    Nucleic Acids Res; 1987 Jan; 15(1):377. PubMed ID: 2881254
    [No Abstract]   [Full Text] [Related]  

  • 33. [Presymptomatic DNA diagnosis in Huntington chorea with linked DNA markers].
    Thies U; Schröder K; Bockel B; Zoll B; Lange H
    Nervenarzt; 1991 Oct; 62(10):615-20. PubMed ID: 1684226
    [No Abstract]   [Full Text] [Related]  

  • 34. Two additional RFLPs at the D4S10 locus, useful for Huntington's disease (HD)-family studies.
    Bakker E; Skraastad MI; Fisser-Groen YM; van Ommen GJ; Pearson PL
    Nucleic Acids Res; 1987 Nov; 15(21):9100. PubMed ID: 2891108
    [No Abstract]   [Full Text] [Related]  

  • 35. Abnormalities of striatal projection neurons and N-methyl-D-aspartate receptors in presymptomatic Huntington's disease.
    Albin RL; Young AB; Penney JB; Handelin B; Balfour R; Anderson KD; Markel DS; Tourtellotte WW; Reiner A
    N Engl J Med; 1990 May; 322(18):1293-8. PubMed ID: 1691447
    [No Abstract]   [Full Text] [Related]  

  • 36. Genetic linkage studies in Huntington disease.
    Pericak-Vance MA; Conneally PM; Merritt AD; Roos R; Norton JA; Vance JM
    Cytogenet Cell Genet; 1978; 22(1-6):640-5. PubMed ID: 156628
    [No Abstract]   [Full Text] [Related]  

  • 37. Sequence analysis of three polymorphic regions in the human genome detected by the G8 probe for RFLPs associated with Huntington's disease.
    Stapleton PM
    Nucleic Acids Res; 1988 Mar; 16(6):2735. PubMed ID: 2896333
    [No Abstract]   [Full Text] [Related]  

  • 38. Neuropathology of Huntington's disease.
    Vonsattel JP; Keller C; Del Pilar Amaya M
    Handb Clin Neurol; 2008; 89():599-618. PubMed ID: 18631782
    [No Abstract]   [Full Text] [Related]  

  • 39. Exclusion mapping of the hereditary dentatorubropallidoluysian atrophy gene from the Huntington's disease locus.
    Kondo I; Ohta H; Yazaki M; Ikeda JE; Gusella JF; Kanazawa I
    J Med Genet; 1990 Feb; 27(2):105-8. PubMed ID: 1969487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mapping of the DNA locus D4S10 and the linked Huntington's disease gene to 4p16----p15.
    Zabel BU; Naylor SL; Sakaguchi AY; Gusella JF
    Cytogenet Cell Genet; 1986; 42(4):187-90. PubMed ID: 2944714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.